PDB Short entry for 2W1C HEADER TRANSFERASE 17-OCT-08 2W1C TITLE STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 122-389; COMPND 5 SYNONYM: AURORA KINASE A, SERINE/THREONINE KINASE 15, COMPND 6 AURORA/IPL1-RELATED KINASE 1, BREAST TUMOR-AMPLIFIED COMPND 7 KINASE, AURORA A, AURORA-A, AURORA-RELATED KINASE 1, COMPND 8 HARK1; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET 23A KEYWDS CANCER, AURORA, KINASE, INHIBITOR, NUCLEOTIDE-BINDING, KEYWDS 2 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KEYWDS 3 POLYMORPHISM, PHOSPHOPROTEIN, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR S.HOWARD,V.BERDINI,J.A.BOULSTRIDGE,M.G.CARR,D.M.CROSS, AUTHOR 2 J.CURRY,L.A.DEVINE,T.R.EARLY,L.FAZAL,A.L.GILL,M.HEATHCOTE, AUTHOR 3 S.MAMAN,J.E.MATTHEWS,R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN, AUTHOR 4 M.O'REILLY,D.C.REES,M.REULE,D.TISI,G.WILLIAMS,M.VINKOVIC, AUTHOR 5 P.G.WYATT REVDAT 2 10-NOV-09 2W1C 1 JRNL REMARK REVDAT 1 27-JAN-09 2W1C 0 JRNL AUTH S.HOWARD,V.BERDINI,J.A.BOULSTRIDGE,M.G.CARR, JRNL AUTH 2 D.M.CROSS,J.CURRY,L.A.DEVINE,T.R.EARLY,L.FAZAL, JRNL AUTH 3 A.L.GILL,M.HEATHCOTE,S.MAMAN,J.E.MATTHEWS, JRNL AUTH 4 R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN,M.O'REILLY, JRNL AUTH 5 D.C.REES,M.REULE,D.TISI,G.WILLIAMS,M.VINKOVIC, JRNL AUTH 6 P.G.WYATT JRNL TITL FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4-YL UREA JRNL TITL 2 (AT9283), A MULTITARGETED KINASE INHIBITOR WITH JRNL TITL 3 POTENT AURORA KINASE ACTIVITY. JRNL REF J.MED.CHEM. V. 52 379 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19143567 JRNL DOI 10.1021/JM800984V REMARK 2 REMARK 2 RESOLUTION. 3.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0069A REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 5301 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.246 REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 283 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.24 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 383 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2880 REMARK 3 BIN FREE R VALUE SET COUNT : 26 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2158 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 71.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.12000 REMARK 3 B22 (A**2) : -0.12000 REMARK 3 B33 (A**2) : 0.17000 REMARK 3 B12 (A**2) : -0.06000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.621 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.469 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 27.545 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.913 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.837 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2247 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1576 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3044 ; 1.315 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3803 ; 1.164 ; 2.979 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 262 ; 6.880 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 110 ;34.368 ;22.691 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 395 ;17.250 ;15.038 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;15.959 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 317 ; 0.061 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2456 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 488 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1313 ; 1.958 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2118 ; 3.424 ; 6.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 934 ; 1.993 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 926 ; 3.332 ; 7.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2W1C COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-OCT-08. REMARK 100 THE PDBE ID CODE IS EBI-37840. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5301 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.24 REMARK 200 RESOLUTION RANGE LOW (A) : 54.50 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 3.9 REMARK 200 R MERGE (I) : 0.06 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.40 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.06433 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 112.12867 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 84.09650 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 140.16083 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.03217 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.06433 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 112.12867 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 140.16083 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 84.09650 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 28.03217 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 121 REMARK 465 GLU A 122 REMARK 465 SER A 123 REMARK 465 LYS A 124 REMARK 465 LYS A 125 REMARK 465 ARG A 126 REMARK 465 HIS A 391 REMARK 465 HIS A 392 REMARK 465 HIS A 393 REMARK 465 HIS A 394 REMARK 465 HIS A 395 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 CYS A 290 SG REMARK 470 GLU A 336 CG CD OE1 OE2 REMARK 470 HIS A 390 CA C O CB CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 358 - NE ARG A 362 2.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 TPO A 288 20.5 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L0C A1391 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC REMARK 900 SERINE-THREONINE KINASE REMARK 900 RELATED ID: 2J50 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA REMARK 900 -739358 REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 REMARK 900 PHOSPHORYLATED ON THR287, THR288 REMARK 900 RELATED ID: 1OL6 RELATED DB: PDB REMARK 900 STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF REMARK 900 AURORA-A REMARK 900 RELATED ID: 2BMC RELATED DB: PDB REMARK 900 AURORA-2 T287D T288D COMPLEXED WITH PHA- REMARK 900 680632 REMARK 900 RELATED ID: 2C6E RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN REMARK 900 COMPLEX WITH A 5-AMINOPYRIMIDINYL REMARK 900 QUINAZOLINE INHIBITOR REMARK 900 RELATED ID: 2J4Z RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA REMARK 900 -680626 REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, REMARK 900 PHOSPHORYLATED ON THR287, THR288 AND BOUND REMARK 900 TO TPX2 1-43 REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN REMARK 900 COMPLEX WITH ADPNP REMARK 900 RELATED ID: 1MQ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE REMARK 900 RELATED ID: 2W1G RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1F RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1I RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1D RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1H RELATED DB: PDB REMARK 900 FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4- REMARK 900 YL UREA (AT9283), A MULTI-TARGETED KINASE REMARK 900 INHIBITOR WITH POTENT AURORA KINASE ACTIVITY REMARK 900 RELATED ID: 2W1E RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR DBREF 2W1C A 121 121 PDB 2W1C 2W1C 121 121 DBREF 2W1C A 122 389 UNP O14965 STK6_HUMAN 122 389 DBREF 2W1C A 390 395 PDB 2W1C 2W1C 390 395 SEQRES 1 A 275 MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU ASP PHE SEQRES 2 A 275 GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN SEQRES 3 A 275 VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE ILE LEU SEQRES 4 A 275 ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA SEQRES 5 A 275 GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SEQRES 6 A 275 SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY SEQRES 7 A 275 TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE LEU GLU SEQRES 8 A 275 TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU GLN LYS SEQRES 9 A 275 LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR TYR ILE SEQRES 10 A 275 THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SER LYS SEQRES 11 A 275 ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU SEQRES 12 A 275 LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY SEQRES 13 A 275 TRP SER VAL HIS ALA PRO SER SER ARG ARG TPO TPO LEU SEQRES 14 A 275 CYS GLY THR LEU ASP TYR LEU PRO PRO GLU MET ILE GLU SEQRES 15 A 275 GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SER LEU SEQRES 16 A 275 GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO SEQRES 17 A 275 PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS ARG ILE SEQRES 18 A 275 SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL THR GLU SEQRES 19 A 275 GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS HIS ASN SEQRES 20 A 275 PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU GLU HIS SEQRES 21 A 275 PRO TRP ILE THR ALA ASN SER SER LYS HIS HIS HIS HIS SEQRES 22 A 275 HIS HIS MODRES 2W1C TPO A 287 THR PHOSPHOTHREONINE MODRES 2W1C TPO A 288 THR PHOSPHOTHREONINE HET TPO A 287 11 HET TPO A 288 11 HET L0C A1391 53 HETNAM L0C 4-{[2-(4-{[(4-FLUOROPHENYL)CARBONYL]AMINO}- HETNAM 2 L0C 1H-PYRAZOL-3-YL)-1H-BENZIMIDAZOL-6-YL]METHYL} HETNAM 3 L0C MORPHOLIN-4-IUM HETNAM TPO PHOSPHOTHREONINE FORMUL 2 L0C C22 H22 N6 O2 F1 FORMUL 3 TPO 2(C4 H10 N O6 P) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 VAL A 174 HIS A 187 1 14 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 SER A 249 1 21 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 PRO A 297 GLY A 303 1 7 HELIX 8 8 LYS A 309 GLY A 325 1 17 HELIX 9 9 THR A 333 ARG A 343 1 11 HELIX 10 10 THR A 353 LEU A 364 1 12 HELIX 11 11 ASN A 367 ARG A 371 5 5 HELIX 12 12 MET A 373 HIS A 380 1 8 HELIX 13 13 HIS A 380 SER A 387 1 8 SHEET 1 AA 5 PHE A 133 GLY A 140 0 SHEET 2 AA 5 VAL A 147 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 2 VAL A 252 ILE A 253 0 SHEET 2 AB 2 VAL A 279 HIS A 280 -1 O VAL A 279 N ILE A 253 SHEET 1 AC 2 LEU A 262 LEU A 264 0 SHEET 2 AC 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 LINK C ARG A 286 N TPO A 287 1555 1555 1.33 LINK C TPO A 287 N TPO A 288 1555 1555 1.33 LINK C TPO A 288 N LEU A 289 1555 1555 1.33 SITE 1 AC1 11 ARG A 137 LYS A 141 VAL A 147 LEU A 194 SITE 2 AC1 11 GLU A 211 TYR A 212 ALA A 213 PRO A 214 SITE 3 AC1 11 GLY A 216 LEU A 263 HIS A 366 CRYST1 82.864 82.864 168.193 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012068 0.006967 0.000000 0.00000 SCALE2 0.000000 0.013935 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005946 0.00000